News
Viewray: ViewRay Announces Results of the First Prospective Clinical Trial on MR-guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Study Shows Low Incidence of Early Toxicity Using Stereotactic Body Radiation
Therapy (SBRT) While Eliminating Potential Complications and Costs Associated
with Implanted Markers
Viewray: MRI-Guided Radiotherapy pioneer, Amsterdam UMC, begins First Clinical Treatments with its Second ViewRay MRIdian Linac System
De Ceunynck Radiotherapy announced today that Amsterdam UMC, location VUmc, has started treating patients with their second MR-guided radiotherapy system, the ViewRay MRIdian® Linac.
Amsterdam UMC is the first European cancer centre to offer radiation therapy with two ViewRay MRIdian® Linac systems, furthering its leadership role in MR-guided radiation therapy.
Viewray: Nog meer patiënten behandelen met revolutionaire bestralingstechniek
VUmc heeft een tweede MRIdian-apparaat aangeschaft voor het bestralen van kankerpatiënten. Zo kunnen nog meer patiënten met nier-, prostaat-, blaas-, borst-, endeldarm-, alvleesklier-, lever- en centrale longkanker behandeld worden met deze precisiebestraling. Bovendien is dit het nieuwe apparaat ‘sneller’ en is de behandeling dus korter.
Read moreViewray: University Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac
MR-Image Guided Linac Treatments in Europe to Commence by Mid-April
Read moreViewray: ESTRO Annual Meeting
De Ceunynck Radiotherapy present @ ESTRO annual meeting 2018 in Barcelona
Read more